GlassScriptPhysician profile
Jose A Chamorro
NPI 1861464562
$1,428.83
in general payments reported to CMS, 2019-2025
22 companies · $28.64 in 2025
The $28.64 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $74.11 · 2021: $110 · 2022: $166 · 2023: $708 · 2024: $119 · 2025: $28.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.80 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $325.49 | 2019-2023 | Myrbetriq |
| E.R. Squibb & Sons, L.L.C. | $273.15 | 2023 | Camzyos |
| Sumitomo Pharma America, INC. | $124.11 | 2023 | Orgovyx, Gemtesa |
| Pfizer INC. | $107.90 | 2019-2023 | |
| Allergan, INC. | $78.89 | 2019-2021 | |
| Abbvie INC. | $68.48 | 2023-2024 | Botox |
| Urovant Sciences INC | $63.26 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.84 | 2024 | Jardiance |
| Myovant Sciences INC. | $39.10 | 2021 | |
| Ferring Pharmaceuticals INC. | $35.83 | 2019 | |
| Verity Pharmaceuticals INC. | $34.49 | 2023 | Trelstar |
| Baxter Healthcare | $28.64 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Boston Scientific Corporation | $27.77 | 2022 | |
| Blue Earth Diagnostics | $24.79 | 2024 | |
| Axonics, INC. | $22.24 | 2023 | Axonics |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.55 | 2022 | |
| Novo Nordisk INC | $19.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.12 | 2024 | |
| Janssen Pharmaceuticals, INC | $17.10 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.35 | 2020 | |
| Currax Pharmaceuticals LLC | $15.03 | 2020 | |
| Dentsply Ih INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Chamorro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.